FDA news

Read verified news on BetaVoices covering FDA, with reporting, context, and related developments.

#FDA Clear filters
FDA proposal would curb bulk compounding of Novo, Lilly weight-loss drugs
Drug compounding

FDA proposal would curb bulk compounding of Novo, Lilly weight-loss drugs

The agency says it sees no clinical need for outsourcing facilities to make bulk compounded versions of semaglutide, tirzepatide and liraglutide when approved drugs are available

Apr 30, 2026

Page 1 of 1